>>Moreover, Alpharma's action forced Pfizer to launch its own authorized generic, putting the drug giant in an awkward position in the pending patent litigation: How is Pfizer going to argue to the court that it would be irreparably harmed by a generic if it was putting one out itself?<<
I'm not sure I see the logic of the comment. Firstly, pfe's action (authorized generic) would have nothing to do with the patent validity. Maybe this could play a role in a damages phase?
Further, pfe certainly is going to lose hundreds of millions in lost revenues and profits because of this, so why not release a generic and try to recoup something? Should they be required to lose as much as possible to ALO?
It would take an awful lot to irreparably harm pfe!
Market Data 
Markets 
AI
